These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 33122069)
21. Nanoparticles mimicking viral surface topography for enhanced cellular delivery. Niu Y; Yu M; Hartono SB; Yang J; Xu H; Zhang H; Zhang J; Zou J; Dexter A; Gu W; Yu C Adv Mater; 2013 Nov; 25(43):6233-7. PubMed ID: 23946251 [TBL] [Abstract][Full Text] [Related]
22. A novel, anisamide-targeted cyclodextrin nanoformulation for siRNA delivery to prostate cancer cells expressing the sigma-1 receptor. Fitzgerald KA; Malhotra M; Gooding M; Sallas F; Evans JC; Darcy R; O'Driscoll CM Int J Pharm; 2016 Feb; 499(1-2):131-145. PubMed ID: 26721726 [TBL] [Abstract][Full Text] [Related]
23. Targeted Treatment of Metastatic Breast Cancer by PLK1 siRNA Delivered by an Antioxidant Nanoparticle Platform. Morry J; Ngamcherdtrakul W; Gu S; Reda M; Castro DJ; Sangvanich T; Gray JW; Yantasee W Mol Cancer Ther; 2017 Apr; 16(4):763-772. PubMed ID: 28138033 [TBL] [Abstract][Full Text] [Related]
24. Glucose-linked sub-50-nm unimer polyion complex-assembled gold nanoparticles for targeted siRNA delivery to glucose transporter 1-overexpressing breast cancer stem-like cells. Yi Y; Kim HJ; Zheng M; Mi P; Naito M; Kim BS; Min HS; Hayashi K; Perche F; Toh K; Liu X; Mochida Y; Kinoh H; Cabral H; Miyata K; Kataoka K J Control Release; 2019 Feb; 295():268-277. PubMed ID: 30639386 [TBL] [Abstract][Full Text] [Related]
25. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug. Beh CW; Seow WY; Wang Y; Zhang Y; Ong ZY; Ee PL; Yang YY Biomacromolecules; 2009 Jan; 10(1):41-8. PubMed ID: 19072631 [TBL] [Abstract][Full Text] [Related]
26. Monodispersed brush-like conjugated polyelectrolyte nanoparticles with efficient and visualized siRNA delivery for gene silencing. Jiang R; Lu X; Yang M; Deng W; Fan Q; Huang W Biomacromolecules; 2013 Oct; 14(10):3643-52. PubMed ID: 24040909 [TBL] [Abstract][Full Text] [Related]
27. Matrix metalloproteinase 2-responsive micelle for siRNA delivery. Wang HX; Yang XZ; Sun CY; Mao CQ; Zhu YH; Wang J Biomaterials; 2014 Aug; 35(26):7622-34. PubMed ID: 24929619 [TBL] [Abstract][Full Text] [Related]
28. Electrostatic Attractive Self-Delivery of siRNA and Light-Induced Self-Escape for Synergistic Gene Therapy. Yang Y; Ning H; Xia T; Du J; Sun W; Fan J; Peng X Adv Mater; 2023 Jul; 35(30):e2301409. PubMed ID: 37084041 [TBL] [Abstract][Full Text] [Related]
29. Tumor acidity-sensitive linkage-bridged block copolymer for therapeutic siRNA delivery. Xu CF; Zhang HB; Sun CY; Liu Y; Shen S; Yang XZ; Zhu YH; Wang J Biomaterials; 2016 May; 88():48-59. PubMed ID: 26945455 [TBL] [Abstract][Full Text] [Related]
30. Cationic bovine serum albumin based self-assembled nanoparticles as siRNA delivery vector for treating lung metastatic cancer. Han J; Wang Q; Zhang Z; Gong T; Sun X Small; 2014 Feb; 10(3):524-35. PubMed ID: 24106138 [TBL] [Abstract][Full Text] [Related]
31. Layer-by-layer nanoparticles as an efficient siRNA delivery vehicle for SPARC silencing. Tan YF; Mundargi RC; Chen MH; Lessig J; Neu B; Venkatraman SS; Wong TT Small; 2014 May; 10(9):1790-8. PubMed ID: 24510544 [TBL] [Abstract][Full Text] [Related]
32. Dendrimer mediated targeting of siRNA against polo-like kinase for the treatment of triple negative breast cancer. Jain A; Mahira S; Majoral JP; Bryszewska M; Khan W; Ionov M J Biomed Mater Res A; 2019 Sep; 107(9):1933-1944. PubMed ID: 31008565 [TBL] [Abstract][Full Text] [Related]
33. Probing the nanoparticle-AGO2 interaction for enhanced gene knockdown. Deshpande S; Singh N Soft Matter; 2018 May; 14(20):4169-4177. PubMed ID: 29687822 [TBL] [Abstract][Full Text] [Related]
34. Monitoring of changes in lipid profiles during PLK1 knockdown in cancer cells using DESI MS. Jayashree B; Srimany A; Jayaraman S; Bhutra A; Janakiraman N; Chitipothu S; Krishnakumar S; Baddireddi LS; Elchuri S; Pradeep T Anal Bioanal Chem; 2016 Aug; 408(20):5623-32. PubMed ID: 27277815 [TBL] [Abstract][Full Text] [Related]
35. Delivery of siRNA by tailored cell-penetrating urea-based foldamers. Bornerie M; Brion A; Guichard G; Kichler A; Douat C Chem Commun (Camb); 2021 Feb; 57(12):1458-1461. PubMed ID: 33438700 [TBL] [Abstract][Full Text] [Related]
36. Charge-reversible lipid derivative: A novel type of pH-responsive lipid for nanoparticle-mediated siRNA delivery. Hirai Y; Saeki R; Song F; Koide H; Fukata N; Tomita K; Maeda N; Oku N; Asai T Int J Pharm; 2020 Jul; 585():119479. PubMed ID: 32473372 [TBL] [Abstract][Full Text] [Related]
38. A pH-sensitive cationic lipid facilitates the delivery of liposomal siRNA and gene silencing activity in vitro and in vivo. Sato Y; Hatakeyama H; Sakurai Y; Hyodo M; Akita H; Harashima H J Control Release; 2012 Nov; 163(3):267-76. PubMed ID: 23000694 [TBL] [Abstract][Full Text] [Related]
39. Stable and efficient transfection of siRNA for mutated KRAS silencing using novel hybrid nanoparticles. Lakshmikuttyamma A; Sun Y; Lu B; Undieh AS; Shoyele SA Mol Pharm; 2014 Dec; 11(12):4415-24. PubMed ID: 25340957 [TBL] [Abstract][Full Text] [Related]
40. Targeting polo-like kinase 1 enhances radiation efficacy for head-and-neck squamous cell carcinoma. Gerster K; Shi W; Ng B; Yue S; Ito E; Waldron J; Gilbert R; Liu FF Int J Radiat Oncol Biol Phys; 2010 May; 77(1):253-60. PubMed ID: 20394857 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]